
John C Wang MD MSc
Interventional Cardiology
Director, Cardiac Catheterization Laboratory at MedStar Union Memorial and Franklin Square Hospital; Scientific Director, Baltimore Cardiovascular Research (MCRN); Director of the Structural Heart Program
201 E University PkwyCardiac Catheterization LabBaltimore, MD 21218
Fax+1 410-554-6544
Overview of Dr. Wang
Dr. John Wang is a cardiologist based in Baltimore, MD, specializing in interventional cardiology. He completed his medical education at the University of Chicago, followed by a residency and fellowships at Brigham and Women's Hospital, including a fellowship in cardiovascular disease and interventional cardiology. He also holds an MSc in Epidemiology from the Harvard School of Public Health. Dr. Wang is experienced in cardiomyopathies, cardiac catheterization, and percutaneous coronary intervention. His research has been published in several journals and includes work on stent outcomes and transcatheter aortic valve replacement. He has led or been involved in multiple clinical trials, such as the IMPact and ACURATE IDE studies, and is a recognized Fellow of both the Society for Cardiovascular Angiography & Interventions and the American College of Cardiology.
Education & Training
Brigham and Women's HospitalFellowship, Interventional Cardiology, 2003 - 2004
Harvard School of Public HealthMSc, Epidemiology, 2002 - 2003
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2000 - 2003
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1997
Certifications & Licensure
MD State Medical License 2004 - 2027
MA State Medical License 1999 - 2012
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (SCAI) Society for Cardiovascular Angiography & Interventions
- Fellow (FACC) American College of Cardiology
Clinical Trials
- The OMEGA Clinical Trial Start of enrollment: 2011 Oct 01
- Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study) Start of enrollment: 2016 May 01
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Novel Technique for Salvaging an Embolized Balloon-Expandable Valve During Transcatheter Mitral Valve Replacement.Lida Koskina, Antony Kaliyadan, John Wang
JACC. Case Reports. 2026-05-22 - First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective Study.Danny Dvir, Hasan A Jilaihawi, Douglas Fraser, Josep Rodes-Cabau, Tamim Nazif
JACC. Cardiovascular Interventions. 2026-05-21 - Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in US Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW VII Trial.David E Kandzari, Hector M Garcia-Garcia, John Wang, Mark Picone, Itsik Ben-Dor
Journal of the Society for Cardiovascular Angiography & Interventions. 2026-03-01
Press Mentions
First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart SurgeryJanuary 13th, 2025
Prolonged Sitting Isn’t Good for Your Health – but Is Prolonged Standing Any Better? Experts Think NotDecember 10th, 2024
MedStar Health Advances Radiation Protection System in Cardiac Catheterization LabOctober 16th, 2024
Professional Memberships
- Fellow
- Society for Cardiovascular Angiography & Interventions - SCAIFellow
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









